Abstract
Screening of 84 primary human breast carcinomas for the mRNA expression of seven angiogenic polypeptides showed that the most commonly expressed and/or the most highly expressed when compared to normal breast tissue were vascular endothelial growth factor (VEGF) and platelet-derived endothelial cell growth factor/thymidine Phosphorylase (PDECGF/TP)1. The neurokines midkine (MK) and pleiotrophin were also fairly commonly expressed in tumour but not normal tissue (unpublished data from this group and ref. 1).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Reif M, LeJeune S, Scott PAE, Fox S, Smith K, Leek R, Moghaddam A, Whitehouse R, Bicknell R, Harris AL. Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, transforming growth factor b-1, platelet-derived endothelial cell growth factor, placental growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis. Cancer Res 57:963–969, 1997
O’Brien T, Cranston D, Fuggle S, Bicknell R, Harris AL. The angiogenic factor midkine is expressed in bladder cancer and overexpression correlates with a poor outcome in patients with invasive cancers. Cancer Res 56: 2515–2518, 1996
Bicknell R. Mechanistic insights into tumour angiogenesis. in “Tumour Angiogenesis” Ed. Bicknell R, Lewis CE, Ferrara N, pp 19–28, Oxford University Press, 1997
Choudhuri R, Zhang H.T., Donnini S, Ziche M, Bicknell R. An angiogenic role for the neurokines midkine and pleiotrophin in tumourigenesis. Cancer Res 57: 1814–1819, 1997
Zhang HT, Craft P, Scott PAE, Ziche M, Weich HA, Harris AL, Bicknell R. Enhancement of tumour growth and vascular density by transfection of vascular endothelial cell growth factor into MCF-7 human breast carcinoma cells. J Natl Cancer Inst 87: 213–219, 1995
Scott PAE. Vascular endothelial growth factor in breast carcinoma. D. Phil thesis, University of Oxford, 1996
Gasparini G. Prognostic and predictive value of intra-tumoral microvessel density in human solid tumours. In “Tumour Angiogenesis” Ed. Bicknell R, Lewis CE Ferrara N, pp 29–44. Oxford University Press, 1997
Moghaddam A and Bicknell R. Expression of platelet-derived endothelial cell growth factor in E coli and confirmation of its thymidine Phosphorylase activity. Biochemistry, 31: 12141–12146, 1992
Usuki K, Saras J, Waltenberger J, Miyazono K, Pierce G, Thomason A, Heldin CH. Platelet-derived endothelial cell growth factor has thymidine Phosphorylase activity. Biochem Biophys Res Commun 184: 1311–1316, 1992
Finnis C., Dodsworth N, Pollitt CE, Carr G and Sleep D. Thymidine Phosphorylase activity of platelet-derived endothelial cell growth factor is responsible for endothelial cell mitogenicity. Eur J Biochem 212: 201–210, 1993
Griffiths L, Dachs GU, Bicknell R, Harris AL and Stratford IJ. The influence of oxygen tension and pH on the expression of platelet-derived endothelial cell growth factor / thymidine Phosphorylase in human breast tumour cells grown in vitro and in vivo. Cancer Res 57: 570–572, 1997
Moghaddam A, Zhang HT, Fan TPD, Hu DE, Lees VC, Turley H, Fox SB, Gatter KC, Harris AL, Bicknell R. Thymidine Phosphorylase is angiogenic and promotes tumour growth. Proc Natl Acad Sci USA 92, 998–1002, 1995
Ishikawa F, Miyazono K, Hellman U, Drexler H, Wernstedt C., Hagiwara K et al. Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factors. Nature 338: 557–562, 1989
Moghaddam A, Choudhuri R, Bicknell R. Thymidine phosphorylase/platelet-derived endothelial cell growth factor: an angiogenic factor, in “Tumour Angiogenesis” Ed. Bicknell R, Lewis CE, Ferrara N, pp 251–260, Oxford University Press, 1997
Reynolds K, Farzaneh F, Collins WP, Campbell S, Bourne TH, Lawton F, Moghaddam A, Harris AL, Bicknell R. Association of ovarian malignancy with expression of platelet-derived endothelial cell growth factor. J Natl Cancer Inst 86: 1234–1238, 1994
Fox SB, Westwood M, Moghaddam A, Comley M, Turley H, Whitehouse RM, Bicknell R, Gatter KC, Harris AL. The angiogenic factor platelet-derived endothelial cell growth factor / thymidine Phosphorylase is up-regulated in breast cancer epithelium. Brit J Cancer 73: 275–280, 1996
Takahashi Y, Bucana CD, Liu W, Yoneda J, Kitadai Y, Cleary KR et al. Platelet-derived endothelial cell growth factor in human colon cancer angiogenesis: role of infiltrating cells. J Natl Cancer Inst 88:1146–1151, 1996
Takebayashi Y, Akiyama S, Akiba S, Yamada K, Miyadera K, Sumizawa T et al. Clinicopathologic and prognostic significance of an angiogenic factor, thymidine Phosphorylase, in human colorectal cancer. J Natl Cancer Inst 88: 1110–1117, 1996
Folkman J. What is the role of thymidine Phosphorylase in tumour angiogenesis? J Natl Cancer Inst 88: 1091–1092, 1996
Haraguchi M, Kazutaka M, Uemura K, Sumizawa T, Furukawa T, Yamada K, Akiyama SI. Angiogenic activity of enzymes. Nature 368: 198, 1994
Jagger RT, Bicknell R. Vascular targeting of anti-cancer gene therapy, in “Tumour Angiogenesis” Ed: Bicknell R, Lewis CE, Ferrara N, pp 357–376, Oxford University Press, 1997
Fox SB, Turner GDH, Gatter KC, Harris AL. The increased expression of adhesion molecules ICAM-3 and E- and P-selectins on breast cancer endothelium. J Pathol 177:369–376, 1995
Brown LF, Berse B, Jackman RW, Tognazzi K, Manseau EJ, Dvorak HF, Senger DR. Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. Am J Pathol 143: 1255–1262, 1993
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Zhang, HT. et al. (1998). Angiogenic Polypeptides in Breast Cancer: Expression of Mrna’s in Primary Human Tumours, MCF-7 Cell Transfection and Xenograft Models. In: Maragoudakis, M.E. (eds) Angiogenesis. NATO ASI Series, vol 298. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9185-3_23
Download citation
DOI: https://doi.org/10.1007/978-1-4757-9185-3_23
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-9187-7
Online ISBN: 978-1-4757-9185-3
eBook Packages: Springer Book Archive